Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:05 PM EDT

Astrazeneca (AZN) Capital Expenditures Growth (5y) (2014 - 2026)

Analysis

Astrazeneca (AZN) Capital Expenditures Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn
2 Hsbc Holdings 362.62 Bn 362.62 Bn -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn
6 Bhp 216.07 Bn 197.52 Bn -
7 Rio Tinto 203.71 Bn 199.33 Bn -
8 Diageo 197.09 Bn 195.06 Bn -
9 Unilever 139.31 Bn 132.28 Bn -
10 Hdfc Bank 117.84 Bn 80.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.51%
Mar 31, 2026 -19.98%
Dec 31, 2025 -23.34%
Sep 30, 2025 -24.65%
Jun 30, 2025 -29.07%
Mar 31, 2025 -18.19%
Dec 31, 2024 -17.21%
Sep 30, 2024 17.59%
Jun 30, 2024 -21.28%
Mar 31, 2024 -19.10%
Jun 30, 2023 0.22%
Mar 31, 2023 -3.01%
Jun 30, 2022 0.77%
Mar 31, 2022 5.20%
Dec 31, 2021 9.57%
Sep 30, 2021 4.54%
Jun 30, 2021 1.90%
Mar 31, 2021 3.80%
Dec 31, 2020 4.38%
Jun 30, 2020 2.60%